From nanoparticles to crystals: one-pot programmable biosynthesis of photothermal gold structures and their use for biomedical applications.
Antibacterial activity
Gold nanoparticles
Green synthesis
Mucin
Photothermal Materials
Protein-templated synthesis
Journal
Journal of nanobiotechnology
ISSN: 1477-3155
Titre abrégé: J Nanobiotechnology
Pays: England
ID NLM: 101152208
Informations de publication
Date de publication:
16 Nov 2022
16 Nov 2022
Historique:
received:
09
08
2022
accepted:
18
10
2022
entrez:
17
11
2022
pubmed:
18
11
2022
medline:
22
11
2022
Statut:
epublish
Résumé
Inspired by nature, green chemistry uses various biomolecules, such as proteins, as reducing agents to synthesize metallic nanostructures. This methodology provides an alternative route to conventional harsh synthetic processes, which include polluting chemicals. Tuning the resulting nanostructure properties, such as their size and shape, is challenging as the exact mechanism involved in their formation is still not well understood. This work reports a well-controlled method to program gold nanostructures' shape, size, and aggregation state using only one protein type, mucin, as a reduction and capping material in a one-pot bio-assisted reaction. Using mucin as a gold reduction template while varying its tertiary structure via the pH of the synthesis, we demonstrate that spherical, coral-shaped, and hexagonal gold crystals can be obtained and that the size can be tuned over three orders of magnitude. This is achieved by leveraging the protein's intrinsic reducing properties and pH-induced conformational changes. The systematic study of the reaction kinetics and growth steps developed here provides an understanding of the mechanism behind this phenomenon. We further show that the prepared gold nanostructures exhibit tunable photothermal properties that can be optimized for various hyperthermia-induced antibacterial applications.
Identifiants
pubmed: 36384747
doi: 10.1186/s12951-022-01680-7
pii: 10.1186/s12951-022-01680-7
pmc: PMC9670439
doi:
Substances chimiques
Gold
7440-57-5
Mucins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
482Subventions
Organisme : National health and research consul of Australia
ID : GNT1112432
Organisme : National health and research consul of Australia
ID : GNT1112432
Organisme : National health and research consul of Australia
ID : GNT1112432
Organisme : National health and research consul of Australia
ID : GNT1112432
Organisme : National health and research consul of Australia
ID : GNT1112432
Organisme : National health and research consul of Australia
ID : GNT1112432
Informations de copyright
© 2022. The Author(s).
Références
Toxicol Res. 2016 Apr;32(2):95-102
pubmed: 27123159
Adv Colloid Interface Sci. 2010 Apr 22;156(1-2):1-13
pubmed: 20181326
Chem Commun (Camb). 2011 Jul 14;47(26):7419-21
pubmed: 21584292
Chem Biol. 2003 Aug;10(8):677-93
pubmed: 12954327
Adv Colloid Interface Sci. 2018 Feb;252:69-82
pubmed: 29329667
Biophys J. 1999 Mar;76(3):1250-8
pubmed: 10049309
Biochem J. 1997 Sep 15;326 ( Pt 3):911-7
pubmed: 9307045
Chem Rev. 2014 Aug 13;114(15):7610-30
pubmed: 25003956
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):844-851
pubmed: 30879351
Sci Rep. 2016 Jun 29;6:28900
pubmed: 27353703
J Biol Chem. 1999 Nov 5;274(45):31751-4
pubmed: 10542193
Appl Environ Microbiol. 2008 Apr;74(7):2171-8
pubmed: 18245232
Biotechnol Rep (Amst). 2020 Jan 31;25:e00427
pubmed: 32055457
Langmuir. 2014 May 27;30(20):5982-8
pubmed: 24784347
Nanoscale. 2018 Jul 13;10(27):12871-12934
pubmed: 29926865
J Nanobiotechnology. 2021 Dec 28;19(1):452
pubmed: 34963478
Macromol Biosci. 2016 Apr;16(4):567-79
pubmed: 26748668
Chem Biol Interact. 2017 Aug 1;273:219-227
pubmed: 28647323
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2015;33(3):286-327
pubmed: 26072980
Mol Biol Evol. 2000 Aug;17(8):1175-84
pubmed: 10908637
Sci Rep. 2018 Jun 25;8(1):9660
pubmed: 29942027
ACS Nano. 2021 Jan 26;15(1):330-337
pubmed: 33284594
Sci Rep. 2020 May 29;10(1):8760
pubmed: 32472040
Bioinformatics. 2008 Feb 15;24(4):498-504
pubmed: 18203772
Chem Rev. 2018 Feb 14;118(3):1169-1198
pubmed: 28699750
Small. 2016 Mar;12(11):1506-13
pubmed: 26763187
Indian J Microbiol. 2016 Dec;56(4):439-444
pubmed: 27784940
Crit Rev Biochem Mol Biol. 1992;27(1-2):57-92
pubmed: 1727693
Biomater Sci. 2018 Aug 21;6(9):2282-2297
pubmed: 30047553
J Pharm Bioallied Sci. 2010 Oct;2(4):282-9
pubmed: 21180459
Macromol Biosci. 2014 Mar;14(3):320-6
pubmed: 24821666
Adv Drug Deliv Rev. 2010 Mar 8;62(3):339-45
pubmed: 19909777
Front Chem. 2020 Apr 23;8:280
pubmed: 32391319
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13057-61
pubmed: 16916929
Nat Commun. 2018 Apr 16;9(1):1489
pubmed: 29662234
J Nanobiotechnology. 2018 Oct 30;16(1):84
pubmed: 30373622
ACS Appl Mater Interfaces. 2017 Oct 4;9(39):33707-33716
pubmed: 28910076
Protein Sci. 2016 Nov;25(11):1918-1923
pubmed: 27599458
J Control Release. 2013 Mar 10;166(2):182-94
pubmed: 23262199
Biomacromolecules. 2005 Nov-Dec;6(6):3458-66
pubmed: 16283779
Sci Rep. 2020 Jun 15;10(1):9616
pubmed: 32541840
J Biol Phys. 2012 Sep;38(4):681-703
pubmed: 24615227
Opt Express. 2016 Jun 13;24(12):13210-9
pubmed: 27410338
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567324
ACS Omega. 2016 Sep 20;1(3):424-434
pubmed: 31457138
Biomimetics (Basel). 2019 Apr 25;4(2):
pubmed: 31105217
Biomacromolecules. 2005 May-Jun;6(3):1329-33
pubmed: 15877349
Sci Rep. 2018 Apr 11;8(1):5802
pubmed: 29643478
Small. 2010 Jan;6(2):262-9
pubmed: 19957282
Biomacromolecules. 2007 May;8(5):1580-6
pubmed: 17402780
Sci Rep. 2018 Jul 16;8(1):10724
pubmed: 30013176
J Am Chem Soc. 2009 Jan 28;131(3):888-9
pubmed: 19123810
J Colloid Interface Sci. 2015 Jun 1;447:254-7
pubmed: 25591824
Adv Mater. 2011 Oct 4;23(37):4261-4
pubmed: 21823175